Parental choice of recall method for HPV vaccination: A pragmatic trial

Pediatrics

Volumn 137, Issue 3, 2016, Pages

  Kempe, Allison ^a,b   O'Leary, Sean T ^a,b   Shoup, Jo Ann ^c   Stokley, Shannon ^d   Lockhart, Steven ^a   Furniss, Anna ^a   Dickinson, L Miriam ^a,e   Barnard, Juliana ^a   Daley, Matthew F ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d KAISER PERMANENTE   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE PRACTICE; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; INTEGRATED HEALTH CARE SYSTEM; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PATIENT CARE; PREFERENCE BASED RECALL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VACCINATION; CLINICAL TRIAL; IMMUNIZATION; MULTICENTER STUDY; PAPILLOMAVIRUS INFECTIONS; PATIENT COMPLIANCE; PROCEDURES; REMINDER SYSTEM; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT COMPLIANCE; REMINDER SYSTEMS; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84960153749     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-2857     Document Type: Article

References (62)

1. Markowitz LE, Dunne EF, Saraiya M, et al; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1-30
2. US Cancer Statistics Working Group. United States cancer statistics: 1999-2011 incidence and mortality Webbased report. 2014. Available at: www.cdc.gov/uscs. Accessed June 29, 2015
3. Benard VB, Watson M, Castle PE, Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012;120(5):1117-1123
4. Chesson HW, Ekwueme DU, Saraiya M, Markowitz LE. Cost-effectiveness of human papillomavirus vaccination in the United States. Emerg Infect Dis. 2008;14(2):244-251
5. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13(1):28-41
6. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24
7. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med. 2006;354(11):1109-1112
8. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708
9. Stokley S, Jeyarajah J, Yankey D, et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620-624
10. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76-82
11. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep. 2013;62(29):591-595
12. Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R. Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: a pilot study. Vaccine. 2012;30(7):1269-1275
13. Vannice KS, Salmon DA, Shui I, et al. Attitudes and beliefs of parents concerned about vaccines: impact of timing of immunization information. Pediatrics. 2011;127(suppl 1):S120-S126
14. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425-433
15. Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L. Overcoming the barriers to HPV vaccination in highrisk populations in the US. Gynecol Oncol. 2010;117(3):486-490
16. Szilagyi PG, Rand CM, McLaurin J, et al; Working Group on Adolescent Vaccination in the Medical Home. Delivering adolescent vaccinations in the medical home: a new era? Pediatrics. 2008;121(suppl 1):S15-S24
17. Tsai Y, Zhou F, Wortley P, Shefer A, Stokley S. Trends and characteristics of preventive care visits among commercially insured adolescents, 2003-2010. J Pediatr. 2014;164(3):625-630
18. Broder KR, Cohn AC, Schwartz B, et al; Working Group on Adolescent Prevention Priorities. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics. 2008;121(suppl 1):S25-S34
19. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics. 2006;118 (5). Available at: www.pediatrics.org/cgi/content/full/118/5/e1287
20. Dombkowski KJ, Lantz PM, Freed GL. Role of health insurance and a usual source of medical care in ageappropriate vaccination. Am J Public Health. 2004;94(6):960-966
21. Kempe A, Saville AW, Dickinson LM, et al. Collaborative centralized reminder/recall notification to increase immunization rates among young children: a comparative effectiveness trial. JAMA Pediatr. 2015;169(4):365-373
22. Kempe A, Saville A, Dickinson LM, et al. Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial. Am J Public Health. 2013;103(6):1116-1123
23. Suh CA, Saville A, Daley MF, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012;129 (6). Available at: www.pediatrics.org/cgi/content/full/129/6/e1437
24. Kempe A, Barrow J, Stokley S, et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics. 2012;129 (6). Available at: www.pediatrics.org/cgi/content/full/129/6/e1446
25. Szilagyi PG, Schaffer S, Barth R, et al. Effect of telephone reminder/recall on adolescent immunization and preventive visits: results from a randomized clinical trial. Arch Pediatr Adolesc Med. 2006;160(2):157-163
26. Jacobson Vann JC, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev. 2005;(3): CD003941
27. Daley MF, Barrow J, Pearson K, et al. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics. 2004;113 (1 pt 1). Available at: www.pediatrics.org/cgi/content/full/113/1pt1/e26
28. Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics. 2003;112(5):1076-1082
29. Szilagyi PG, Schaffer S, Shone L, et al. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices. Pediatrics. 2002;110 (5). Available at: www.pediatrics.org/cgi/content/full/110/5/e58
30. Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA. 2000;284(14):1820-1827
31. Szilagyi PG, Rodewald LE, Savageau J, Yoos L, Doane C. Improving influenza vaccination rates in children with asthma: a test of a computerized reminder system and an analysis of factors predicting vaccination compliance. Pediatrics. 1992;90(6):871-875
32. Dickinson LM, Beaty B, Fox C, et al. Achieving balanced study arms in pragmatic cluster randomized trials using covariate constrained randomization. J Am Board Fam Pract. 2015;28(5):663-672
33. Kraschnewski JL, Keyserling TC, Bangdiwala SI, et al. Optimized probability sampling of study sites to improve generalizability in a multisite intervention trial. Prev Chronic Dis. 2010;7(1):A10
34. Moulton LH, Golub JE, Durovni B, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4(2):190-199
35. Chaudhary MA, Moulton LH. A SAS macro for constrained randomization of group-randomized designs. Comput Methods Programs Biomed. 2006;83(3):205-210
36. Raab GM, Butcher I. Balance in cluster randomized trials. Stat Med. 2001;20(3):351-365
37. Dorell CG, Stokley S, Yankey D, Markowitz LE. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009. Vaccine. 2012;30(3):503-505
38. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940-943
39. Szilagyi PG, Albertin C, Humiston SG, et al. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr. 2013;13(3):204-213
40. Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine. 2011;29(14):2537-2541
41. Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015;56(1):85-90
42. Morris J, Wang W, Wang L, Peddecord KM, Sawyer MH. Comparison of reminder methods in selected adolescents with records in an immunization registry. J Adolesc Health. 2015;56(suppl 5):S27-S32
43. Berkowitz SA, Traore CY, Singer DE, Atlas SJ. Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network. Health Serv Res. 2015;50(2):398-417
44. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures-the public health disparities geocoding project. Am J Public Health. 2003;93(10):1655-1671
45. Irigoyen MM, Findley S, Wang D, et al. Challenges and successes of immunization registry reminders at inner-city practices. Ambul Pediatr. 2006;6(2):100-104
46. Le Baron CW, Starnes DM, Rask KJ. The impact of reminder-recall interventions on low vaccination coverage in an inner-city population. Arch Pediatr Adolesc Med. 2004;158(3):255-261
47. Daley MF, Steiner JF, Brayden RM, Xu S, Morrison S, Kempe A. Immunization registry-based recall for a new vaccine. Ambul Pediatr. 2002;2(6):438-443
48. Ahlers-Schmidt CR, Chesser A, Hart T, Paschal A, Nguyen T, Wittler RR. Text messaging immunization reminders: feasibility of implementation with low-income parents. Prev Med. 2010;50(5-6):306-307
49. Blumberg SJ, Luke JV. Reevaluating the need for concern regarding noncoverage bias in landline surveys. Am J Public Health. 2009;99(10):1806-1810
50. Blumberg SJ, Luke JV, Cynamon ML. Telephone coverage and health survey estimates: evaluating the need for concern about wireless substitution. Am J Public Health. 2006;96(5):926-931
51. Vilella A, Bayas JM, Diaz MT, et al. The role of mobile phones in improving vaccination rates in travelers. Prev Med. 2004;38(4):503-509
52. Lee S, Elkasabi M, Streja L. Increasing cell phone usage among Hispanics: implications for telephone surveys. Am J Public Health. 2012;102(6):e19-e24
53. Zickuhr K, Smith A. Digital differences. 2012. Available at: www.pewinternet.org/2012/04/13/digital-differences/. Accessed June 29, 2015
54. Smith A. Mobile access 2010. Available at: www.pewinternet.org/2010/07/07/mobile-access-2010/. Accessed June 29, 2015
55. Clark SJ, Butchart A, Kennedy A, Dombkowski KJ. Parents' experiences with and preferences for immunization reminder/recall technologies. Pediatrics. 2011;128 (5). Available at: www.pediatrics.org/cgi/content/full/128/5/e1100
56. Saville AW, Beaty B, Dickinson LM, Lockhart S, Kempe A. Novel immunization reminder/recall approaches: rural and urban differences in parent perceptions. Acad Pediatr. 2014;14(3):249-255
57. Hofstetter AM, Vargas CY, Kennedy A, Kitayama K, Stockwell MS. Parental and provider preferences and concerns regarding text message reminder/recall for early childhood vaccinations. Prev Med. 2013;57(2):75-80
58. Shoup JA, Madrid C, Koehler C, et al. Effectiveness and cost of influenza vaccine reminders for adults with asthma or chronic obstructive pulmonary disease. Am J Manag Care. 2015;21(7):e405-e413
59. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine. 2011;29(17):3138-3143
60. Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010;47(6):596-599
61. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a universitybased health system. Vaccine. 2010;28(4):989-995
62. Centers for Medicare and Medicaid Services. 2014 Definition Stage 1 of Meaningful Use. EHR Incentive Programs 2014. Available at: www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Meaningful-Use.html. Accessed June 29, 2015